284 related articles for article (PubMed ID: 19900520)
21. N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34.
Zhao SH; Wu XT; Guo WC; Du YM; Yu L; Tang J
Int J Pharm; 2010 Jun; 393(1-2):268-72. PubMed ID: 20435115
[TBL] [Abstract][Full Text] [Related]
22. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
23. [Research on thymopentin-loaded N-trimethyl chitosan nanoparticles administered through mouth].
Tang SW; Yuan XJ; Zhang ZR; Song QG; He Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):885-8. PubMed ID: 17953385
[TBL] [Abstract][Full Text] [Related]
24. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
Sayin B; Somavarapu S; Li XW; Sesardic D; Senel S; Alpar OH
Eur J Pharm Sci; 2009 Nov; 38(4):362-9. PubMed ID: 19733658
[TBL] [Abstract][Full Text] [Related]
25. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
Ofokansi K; Winter G; Fricker G; Coester C
Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
[TBL] [Abstract][Full Text] [Related]
26. The gene transfection efficiency of thermoresponsive N,N,N-trimethyl chitosan chloride-g-poly(N-isopropylacrylamide) copolymer.
Mao Z; Ma L; Yan J; Yan M; Gao C; Shen J
Biomaterials; 2007 Oct; 28(30):4488-500. PubMed ID: 17640726
[TBL] [Abstract][Full Text] [Related]
27. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
Csaba N; Köping-Höggård M; Alonso MJ
Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
[TBL] [Abstract][Full Text] [Related]
28. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
29. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect.
Ozbaş-Turan S; Akbuğa J; Enneli B
Pharmazie; 2009 Dec; 64(12):807-11. PubMed ID: 20095138
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
[TBL] [Abstract][Full Text] [Related]
32. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
[TBL] [Abstract][Full Text] [Related]
33. Receptor mediated gene delivery by folate conjugated N-trimethyl chitosan in vitro.
Zheng Y; Cai Z; Song X; Yu B; Bi Y; Chen Q; Zhao D; Xu J; Hou S
Int J Pharm; 2009 Dec; 382(1-2):262-9. PubMed ID: 19686829
[TBL] [Abstract][Full Text] [Related]
34. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
Bal SM; Slütter B; van Riet E; Kruithof AC; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
J Control Release; 2010 Mar; 142(3):374-83. PubMed ID: 19932723
[TBL] [Abstract][Full Text] [Related]
35. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
[TBL] [Abstract][Full Text] [Related]
36. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
37. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.
Aktaş Y; Yemisci M; Andrieux K; Gürsoy RN; Alonso MJ; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Riguera R; Sargon MF; Celik HH; Demir AS; Hincal AA; Dalkara T; Capan Y; Couvreur P
Bioconjug Chem; 2005; 16(6):1503-11. PubMed ID: 16287248
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
Yan C; Chen D; Gu J; Qin J
J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
[TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
